Skip to content
Robots, Ranked.
Surgical / Medical

Sentante Endovascular Robotic System

Built by Sentante · LT

Updated Sep 2026·methodology
Ask Scout

The Sentante Endovascular Robotic System is a Surgical / Medical robot developed by Sentante (LT), launched 2026. Key specifications: haptic feedback Yes.

RoboScore

41.3/ 100

Speculative — thin evidence

No confirmed deployment on record — this score reflects the rest of the record, not verified adoption.

3 of 9 signals present

Recomputed nightly from public data. Missing data is skipped, never zero-filled — and rankings are never for sale.

Weighted factors

average of the 3 scored · blanks don't count

Commercial maturity20%75/100
Deployment footprint20%unknown
Proven track record12%unknown
Spec completeness12%54/100
Company financial health12%unknown
Company maturity8%45/100
Manufacturer portfolio6%unknown
Media mentions (trailing 12 months)6%unknown
Independent recognition4%unknown

Ranked #51 of 59 in the Surgical / Medical standing.

See the standing
Where it has stood41 days · best #42 · worst #51
#1 · started #45#59

Nothing changed about Sentante Endovascular Robotic System itself — these days are its maker's news:

  • 26 Aug Its maker's news lifted the score 1.76 — the board noticed.

One reading per day since 3 Aug, when the current ordering began. The rank above is the reading for 12 Sept, taken against 59 robots — the standing itself is live, so a robot added since then counts there and not here yet.

Will it fit your job?

Tell us the job in plain words — we'll show how this robot measures up, line by line.

No needs set yet

Tell us what your job needs — payload, budget, region, must-have certifications — and we'll show how Sentante Endovascular Robotic System measures up, requirement by requirement. The RoboScore (trust) above is shown for every buyer, regardless.

Overview

The Sentante Endovascular Robotic System is a haptic, teleoperated endovascular platform that lets a clinician perform vascular procedures such as balloon angioplasty and stent delivery remotely, using standard guidewires and catheters, while a bedside robot replicates the operator's hand movements in real time. It received a CE mark in May 2026 following the ESSENTIAL first-in-human study in Riga, Latvia.

At a glance

  • Built for surgical assistance
  • Used across hospital
  • Certified to CE mark
  • Sold in European Union

Buyer decision signals

Viability

US$6.6M raised in 1 confirmed roundest. 2017

Availability

CE-marked

Specifications

Detailed specifications pending — claim this page to add yours.

Company profile

Confirmed funding
US$6.6M· 1 round
Founded
2017

Detailed specifications

What it is built for2
Applications
surgical assistance
Industries Served
hospital
Controls & integration2
Mounting Options
bedside robotic unit,remote workstation
Compatible Vision
X-ray,fluoroscopy
Safety & certification1
Safety Certification
CE mark
Buying & support3
Country Of Origin
Lithuania
Availability Status
CE-marked
Countries Available
European Union
Other details4
Source
news-discovery + web-verified 2026-07-19
Indication
Endovascular / vascular intervention (angioplasty, stenting)
Distinctive
Remote teleoperation with haptic feedback
Regulatory Status
CE mark (May 2026); not FDA-cleared

Who runs it· deployment evidence

No deployment evidence on file

A deployment is recorded when a public source names the customer, or the maker confirms it. Nothing here counts against this robot.

10 other robots in this category have one.

Add a deployment →

Where to buy

Get a price or reach an authorized seller — pick your region, then request a quote.

No authorized seller is listed for this robot yet — request a quote below and we’ll connect you with Sentante or an authorized seller.

Request a quote — goes straight to Sentante.

Where will these robots operate? Often the same as your country — add more for multi-country deployments.

Your request goes to Sentante.

Every authorized seller serving your region is shown equally — placement is never sold, and this data never affects a robot’s score. A seller’s absence here doesn’t mean they aren’t authorized.

Frequently asked questions

Who makes the Sentante Endovascular Robotic System?
The Sentante Endovascular Robotic System is developed by Sentante, based in LT.
What type of robot is the Sentante Endovascular Robotic System?
The Sentante Endovascular Robotic System is a Surgical / Medical robot made by Sentante.
How much does the Sentante Endovascular Robotic System cost?
Pricing for the Sentante Endovascular Robotic System is not publicly listed — contact Sentante for a quote.
When was the Sentante Endovascular Robotic System launched?
The Sentante Endovascular Robotic System was launched in 2026.
What are the key specifications of the Sentante Endovascular Robotic System?
Key specifications of the Sentante Endovascular Robotic System: haptic feedback Yes.

Reviews for Sentante Endovascular Robotic System

Loading reviews…

Get pricing from

Sentante

Buyers also compared this with

Related reading

Industry Knowledge →